Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

47.18
-0.9900-2.06%
Post-market: 47.500.3200+0.68%19:58 EDT
Volume:7.90M
Turnover:376.02M
Market Cap:95.43B
PE:15.09
High:48.23
Open:48.16
Low:47.13
Close:48.17
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:2.14
T/O Rate:0.41%
Dividend:1.80
Dividend Rate:3.81%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.10
PE(LYR):12.63

Loading ...

Movement Alert|GlaxoSmithKline PLC Rises 4.44% in Regular Trading, Q2 Revenue and Earnings Both Beat Expectations with Cost Savings Target Boosting Confidence

Market Focus
·
Jul 28

GSK to Build New Global Research Center in Cambridge

MT Newswires Live
·
Jul 28

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Tuesday

MT Newswires Live
·
Jul 28

GSK's R&D Plan Looks Smart

Dow Jones
·
Jul 28

GSK's Savings Plan Can Offset Profitability Hit from HIV Patent Expiration

Dow Jones
·
Jul 28

GSK sees 2031 sales over GBP 40B

TIPRANKS
·
Jul 28

GSK sees 70p per share dividend for FY26

TIPRANKS
·
Jul 28

GSK initiates ‘Accelerate Growth’ program

TIPRANKS
·
Jul 28

GSK Q2 Core Earnings, Sales Rise; Reaffirms 2026 Guidance

MT Newswires Live
·
Jul 28

GSK reports Q2 core EPS 50.5p, up 9% at CER

TIPRANKS
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Revenue of 8.41B Pounds ($11.17B), vs. FactSet Est of 8.28B Pounds

MT Newswires Live
·
Jul 28

Earnings Flash (GSK) GSK Posts Q2 Core EPS 50.5 Pence, vs. FactSet Est of $46.47 Pence

MT Newswires Live
·
Jul 28

Stock Track | GSK Soars 5% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Data

Stock Track
·
Jul 28

GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate

Benzinga Earnings
·
Jul 28

Sweeping job cuts at GSK to fund £400m Cambridge campus

cityam
·
Jul 28

GSK’s partner posts positive osteosarcoma data for B7-H3 drug, bolstering oncology push

TIPRANKS
·
Jul 28

GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank

TIPRANKS
·
Jul 28

GSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study

TIPRANKS
·
Jul 28

GSK Climbs Monday, Outperforms Market

Dow Jones
·
Jul 28

GSK Strategy Update in Focus

Dow Jones
·
Jul 27